Pharmacokinetics and systemic tolerance of butorphanol tartrate after intravenous administration in horses

Wiener Tierarztliche Monatsschrift

Volumn 94, Issue 3-4, 2007, Pages 64-70

  Van Den Hoven, R ^a,c   Leinker, S ^a,c   Spadavecchia, G ^b,d   Mosing, M ^a,b,c   Auer, U ^a,b,c  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b UNIVERSITY OF BERN   (Switzerland)

^c Department of Companion Animal Clinical Science ^*  (Austria)

^d NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

Author keywords

Butorphanol; Horses; Pharmacodynamics; Pharmacokinetics

Indexed keywords

EQUIDAE;

EID: 34248401648     PISSN: 0043535X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. ANONYMUS (1998): Committee for Veterinary Medicinal Products. Butorphanol Tartrate. Summary Report. EMEA/MRL/323/97-Final.
2. BAGGOT, J.D. (1977): Principles of drug disposition in domestic animals. Saunders, Philadelphia, London, Toronto.
3. BAGGOT, J.D. (2001): Pharmacokinetic terms: symbols and units. J. Vet. Pharm. Therap. 24, 81-82.
4. BENNETT, R.C., STEFFEY, E.P. (2002): Use of opioids for pain and anesthetic management in horses. Vet. Clin. North. Am. Equine Pract. 18, 47-60.
5. BLACKMORE, D.J., ELTON, D. (1975): Enzyme activity in the serum of thoroughbred horses in the United Kingdom. Equine Vet. J. 7, 34-39.
6. COMMISKEY, S., FAN, L.W., HO, I. K., ROCKHOLD, R.W. (2005): Butorphanol: effects of a prototypical agonist-antagonist analgesic on kappa-opioid receptors. J. Pharmacol. Sci. 98, 109-116.
7. DOBKIN, A.B., EAMKOAOW, S., ZAK, S., CARUSO, F.S. (1974): Butorphanol: a double-blind evaluation in post-operative patients with moderate to severe pain. Can. Anaesth. Soc. J. 21, 600-610.
8. ELLISON, R.E., JACOBS, R.M. (1990): An attempt to determine the tissue origin of equine serum alkaline phosphatase by iso-electric focusing. Can. J. Vet. Res. 54, 119-125.
9. GAVER, R.C., VASILJEV, M., WONG, H., MONKOVIC, I., SWIGOR, J.E., HARKEN, D.R. van, SMYTH, R.D. (1980): Disposition of parenteral butorphanol in man. Drug Metab. Disposition 8, 230-235.
10. HEEL, R.C., BROGDEN, R.N., SPEIGHT, T.M., AVERY, G.S. (1978): Butorphanol: a review of its pharmacological properties and therapeutic efficacy. Drugs 16, 473-505.
11. HORAN, P.J., HO, I.K. (1989): Comparative pharmacological and biochemical studies between butorphanol and morphine. Pharmacol. Biochem. & Behav. 34, 847-854.
12. KALPRAVIDH, M., LUMB, W.V., WRIGHT, M., HEATH, R.B. (1984): Analgesic effects of butorphanol in horses: dose-response studies. Am. J. Vet. Res. 45, 211-216.
13. KOHN, C.W., MUIR III, W.W. (1988): Selected aspects of the clinical pharmacology of visceral analgesics and gut motility modifying drugs in the horse. J. Vet. Int. Med. 2, 85-91.
14. MULVANA, D.E., DUNCAN, G.F., SHYU, W.C., TAY, L.K., BARBHAIYA, R.H. (1996): Quantitative determination of butorphanol and its metabolites in human plasma by gas-electron capture negative-ion chemical ionization mass spectrometry. J. Chromatography B. 682, 289-300.
15. ROBERTSON, J.T., MUIR, W.W., SAMS, R. (1981): Cardiopulmonary effects of butorphanol tartrate in horses. Am. J. Vet. Res. 42, 41-44.
16. SELLON, D.C., MONROE, V.L., ROBERTS, M.C., PAPICH, M.G. (2001): Pharmacokinetics and adverse effects of butorphanol administered by single intravenous injection or continuous intravenous infusion in horses. Am. J. Vet. Res. 62, 183-189.
17. SKARDA, R.T., MUIR III, W.W. (2003): Comparison of electroacupuncture and butorphanol on respiratory and cardiovascular effects and rectal pain threshold after controlled rectal distension in mares. Am. J. Vet. Res. 64, 137-144.
18. SPADAVECCHIA, C., SPADAVECCHIA, L., ANDERSEN, O.K., ARENDT-NIELSEN, L., LEANDRI, M., SCHATZMANN, U. (2002): Quantitative assessment of nociception in horses by use of the nociceptive withdrawal reflex evoked by transcutaneous electrical stimulation. Am. J. Vet. Res. 63, 1551-1556.
19. YAMAOKA, K., NAKAGAWA, T., UNO, T. (1978): Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J. Pharmacokin. Pharmakodyn. 6, 165-175.